JP2011506941A5 - - Google Patents

Download PDF

Info

Publication number
JP2011506941A5
JP2011506941A5 JP2010537302A JP2010537302A JP2011506941A5 JP 2011506941 A5 JP2011506941 A5 JP 2011506941A5 JP 2010537302 A JP2010537302 A JP 2010537302A JP 2010537302 A JP2010537302 A JP 2010537302A JP 2011506941 A5 JP2011506941 A5 JP 2011506941A5
Authority
JP
Japan
Prior art keywords
seprase
cancer
esophagus
colon
stomach
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010537302A
Other languages
English (en)
Japanese (ja)
Other versions
JP5563988B2 (ja
JP2011506941A (ja
Filing date
Publication date
Priority claimed from EP07023897A external-priority patent/EP2071337A1/en
Application filed filed Critical
Priority claimed from PCT/EP2008/010385 external-priority patent/WO2009074275A1/en
Publication of JP2011506941A publication Critical patent/JP2011506941A/ja
Publication of JP2011506941A5 publication Critical patent/JP2011506941A5/ja
Application granted granted Critical
Publication of JP5563988B2 publication Critical patent/JP5563988B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010537302A 2007-12-10 2008-12-08 癌のマーカーとしてのセプラーゼ Expired - Fee Related JP5563988B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP07023897.7 2007-12-10
EP07023897A EP2071337A1 (en) 2007-12-10 2007-12-10 Seprase as a marker for cancer
EP08015310 2008-08-29
EP08015310.9 2008-08-29
PCT/EP2008/010385 WO2009074275A1 (en) 2007-12-10 2008-12-08 Seprase as a marker for cancer

Publications (3)

Publication Number Publication Date
JP2011506941A JP2011506941A (ja) 2011-03-03
JP2011506941A5 true JP2011506941A5 (cg-RX-API-DMAC7.html) 2011-10-06
JP5563988B2 JP5563988B2 (ja) 2014-07-30

Family

ID=40373548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010537302A Expired - Fee Related JP5563988B2 (ja) 2007-12-10 2008-12-08 癌のマーカーとしてのセプラーゼ

Country Status (14)

Country Link
US (1) US8980573B2 (cg-RX-API-DMAC7.html)
EP (1) EP2223115B1 (cg-RX-API-DMAC7.html)
JP (1) JP5563988B2 (cg-RX-API-DMAC7.html)
KR (1) KR101202220B1 (cg-RX-API-DMAC7.html)
CN (1) CN101896818B (cg-RX-API-DMAC7.html)
AT (1) ATE524740T1 (cg-RX-API-DMAC7.html)
AU (1) AU2008335855B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0820793A2 (cg-RX-API-DMAC7.html)
CA (1) CA2706115A1 (cg-RX-API-DMAC7.html)
DK (1) DK2223115T3 (cg-RX-API-DMAC7.html)
ES (1) ES2372442T3 (cg-RX-API-DMAC7.html)
MX (1) MX2010004671A (cg-RX-API-DMAC7.html)
PL (1) PL2223115T3 (cg-RX-API-DMAC7.html)
WO (1) WO2009074275A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8213005B2 (en) 2003-07-22 2012-07-03 King Saud University Method for discriminating between benign and malignant prostate tumors
EP2297581B1 (en) * 2008-07-03 2013-04-03 F. Hoffmann-La Roche AG Asc as a marker for lung cancer
NZ702527A (en) 2009-12-20 2016-07-29 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2013519095A (ja) * 2010-02-05 2013-05-23 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
JP6026422B2 (ja) * 2010-10-20 2016-11-16 ラッシュ ユニバーシティ メディカル センターRush University Medical Center 肺がん試験
CN103403555B (zh) 2011-03-11 2015-06-24 霍夫曼-拉罗奇有限公司 Asc作为慢性阻塞性肺病(copd)的标志物
EP2684049A1 (en) * 2011-03-11 2014-01-15 Roche Diagniostics GmbH Seprase as marker for chronic obstructive pulmonary disease (copd)
CN102435748B (zh) * 2011-11-25 2014-07-16 广东药学院 一种双抗夹心酶联免疫检测试剂盒及其制备方法
EP3540440B1 (en) 2011-12-08 2022-09-28 Astute Medical, Inc. Methods and uses for evaluating renal injury and renal status
EA201492284A1 (ru) 2012-06-27 2015-11-30 Берг Ллк Применение маркеров в диагностике и лечении рака предстательной железы
EP2919910B1 (en) 2012-11-09 2017-12-20 Roche Diagnostics GmbH In vitro capture and analysis of circulating tumor cells
CN104969071B (zh) * 2012-11-30 2019-09-03 迪森德克斯公司 用于评估结肠肿瘤的存在或风险的方法
JP6681195B2 (ja) 2013-01-17 2020-04-15 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
US9753037B2 (en) 2013-03-15 2017-09-05 Rush University Medical Center Biomarker panel for detecting lung cancer
CN103267852B (zh) * 2013-05-15 2015-03-25 中国医学科学院北京协和医院 成纤维激活蛋白α在制备胰腺癌预后试剂盒中的用途
KR101619122B1 (ko) 2013-08-14 2016-05-10 연세대학교 산학협력단 탈메틸화 의존적 asc 발현을 촉진시켜서 대장암 종양세포의 사멸감수성을 증진시키는 항암제 병용 투여용 후보물질의 스크리닝 방법
WO2015088947A1 (en) 2013-12-09 2015-06-18 Rush University Medical Center Biomarkers of rapid progression in advanced non-small cell lung cancer
PL230661B1 (pl) * 2014-01-29 2018-11-30 Centrum Onkologii Inst Im Marii Sklodowskiej Curie Oddzial W Gliwicach Metoda predykcyjna in vitro do przewidywania i/lub wykluczenia obecnosci raka pluc, zastosowanie in vitro metody predykcyjnej oraz zestaw testowy do wykrywania in vitro raka pluc
EP2916134B1 (en) * 2014-03-05 2017-08-16 Roche Diagnostics GmbH Use of Seprase for differential diagnosis of acute dyspnea
CN107428821B (zh) 2014-12-08 2022-06-24 博格有限责任公司 包括细丝蛋白a的标志物在诊断和治疗前列腺癌中的用途
WO2016146174A1 (en) * 2015-03-17 2016-09-22 Biontech Ag Compositions and methods for diagnosis and treatment of cancer
CA2982169A1 (en) 2015-04-10 2016-10-13 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
JP2018035137A (ja) 2016-07-13 2018-03-08 マブイミューン ダイアグノスティックス エイジーMabimmune Diagnostics Ag 新規な抗線維芽細胞活性化タンパク質(fap)結合薬剤およびその使用
WO2018020530A1 (ja) * 2016-07-25 2018-02-01 静岡県 肝外胆管癌、肝内胆管癌、又は胆嚢癌の診断用バイオマーカー
JP7162592B2 (ja) 2016-12-14 2022-10-28 パーデュー・リサーチ・ファウンデイション 線維芽細胞活性化タンパク質(fap)標的イメージングおよび治療
DE102017010455A1 (de) * 2017-06-13 2018-12-13 Forschungszentrum Jülich GmbH Verfahren zum Nachweis von Aggregaten biotherapeutischer Substanzen in einer Probe
CA3074684A1 (en) * 2017-09-05 2019-03-14 Oncotag Diagnostics Co., Ltd. Method for diagnosing pancreatic cancer using methionyl-trna synthetase, and pancreatic cancer diagnostic kit using same
WO2022007283A1 (zh) * 2020-07-08 2022-01-13 深圳霁因生物医药转化研究院 用于诊断fap表达异常相关疾病的试剂盒、方法及计算机可读存储介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0953639A1 (en) * 1998-04-30 1999-11-03 Boehringer Ingelheim International GmbH FAPalpha-specific antibody with improved producibility
AU2004286307A1 (en) * 2003-10-31 2005-05-12 Vitatex, Inc. Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
US7968308B2 (en) * 2004-10-22 2011-06-28 Danisco Us Inc. Isolating human antibodies
EP1760076A1 (en) * 2005-09-02 2007-03-07 Ferring B.V. FAP Inhibitors
CN101379069A (zh) * 2005-12-19 2009-03-04 塔夫茨大学信托人 软蛋白酶抑制剂及其前软形式

Similar Documents

Publication Publication Date Title
JP2011506941A5 (cg-RX-API-DMAC7.html)
US20230116530A1 (en) Method for detecting nucleosomes containing histone variants
Lim et al. An electrochemical peptide sensor for detection of dengue fever biomarker NS1
Gao et al. Multiplexed detection of lung cancer biomarkers in patients serum with CMOS-compatible silicon nanowire arrays
Wang et al. Detection of prostate specific antigen in whole blood by microfluidic chip integrated with dielectrophoretic separation and electrochemical sensing
CA2845993C (en) Method for detecting nucleosomes containing nucleotides
US20220214345A1 (en) Colorectal cancer screening examination and early detection method
MX2008009592A (es) Metodos y composiciones para identificar pacientes con una probabilidad incrementada de tener cancer de ovario.
CN104597240B (zh) 石墨烯/类过氧化物酶双信号放大检测白血病的生物传感方法
IL192866A (en) Detecting cancer with high levels of 2 bcl
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
JP2014531573A5 (cg-RX-API-DMAC7.html)
JP2013521763A5 (cg-RX-API-DMAC7.html)
Dong et al. A highly sensitive colorimetric aptasensor for the detection of the vascular endothelial growth factor in human serum
WO2008151110A3 (en) Molecular diagnosis and typing of lung cancer variants
CN103898205A (zh) 半胱氨酸蛋白酶抑制剂sn的应用
Wang et al. MXenes-Au NPs modified electrochemical biosensor for multiple exosome surface proteins analysis
Sousa et al. Recent advances in the selection of cancer-specific aptamers for the development of biosensors
Park et al. Subunit-specific mass spectrometry method identifies haptoglobin subunit alpha as a diagnostic marker in non-small cell lung cancer
Lin et al. An enzyme-free fluorescent biosensor for highly sensitive detection of carcinoembryonic antigen based on aptamer-induced entropy-driven circuit
CN103278621A (zh) 一种利用生物传感器与血糖仪检测转录因子的方法
JP2016535270A5 (cg-RX-API-DMAC7.html)
Wang et al. An ultrasensitive label-free electrochemical impedimetric immunosensor for vascular endothelial growth factor based on specific phage via negative pre-screening
Chen et al. Electrochemical identification of hepatocellular carcinoma based on the assay of human cervical cancer oncoprotein-1 in serum
Ye et al. Nanostructures and nanotechnologies for the detection of extracellular vesicle